A client has been diagnosed with chronic hepatitis B infection. What antiviral agents may the nurse expect to be prescribed for this client's treatment? (Select all that apply)

Choice A rationale:

Fatigue is a common side effect of antiviral therapy for hepatitis

C. The medications used to treat hepatitis C can cause general fatigue and tiredness in some patients. The nurse should monitor the client for signs of increased fatigue and address any concerns.

Choice D rationale:

Muscle aches are another possible side effect of antiviral therapy for hepatitis

C. Some patients may experience muscle pain or discomfort while on these medications. The nurse should assess the client for muscle aches and provide appropriate interventions if necessary.

Choice E rationale:

Blurred vision can occur as a side effect of antiviral therapy for hepatitis

C. Some medications used in the treatment of hepatitis C can affect vision in some patients. The nurse should be vigilant in monitoring the client's visual acuity and report any changes to the healthcare provider.

Choice B rationale:

Insomnia is not a common side effect of antiviral therapy for hepatitis

C. While some individuals may experience sleep disturbances due to the stress of managing a chronic condition, insomnia is not directly related to the antiviral medications used in hepatitis C treatment.

Choice C rationale:

Headache is not a typical side effect of antiviral therapy for hepatitis

C. Headaches may occur for various reasons, but they are not directly associated with the medications used to treat hepatitis

C.

Choice A rationale:

Elevated HCV RNA levels indicate ongoing active viral replication and are not indicative of an effective response to antiviral therapy. The goal of antiviral therapy is to suppress viral replication, leading to decreased or undetectable HCV RNA levels.

Choice B rationale:

Presence of anti-HCV antibodies is a marker of past or current exposure to hepatitis C virus. While it indicates the client's immune response to the virus, it does not provide information about the effectiveness of antiviral therapy in suppressing viral replication.

Choice C rationale:

Detectable HCV core antigen suggests the presence of the virus but does not provide information about viral replication or the effectiveness of antiviral therapy in reducing viral load.

Choice D rationale:

Undetectable HCV RNA 12 weeks after treatment is considered a sustained virological response (SVR) and indicates an effective response to antiviral therapy. SVR means that the virus is undetectable in the blood even after the completion of treatment, which indicates successful viral clearance.